Literature DB >> 21181719

The mechanism of papain inhibition by peptidyl aldehydes.

Michael Shokhen1, Netaly Khazanov, Amnon Albeck.   

Abstract

Various mechanisms for the reversible formation of a covalent tetrahedral complex (TC) between papain and peptidyl aldehyde inhibitors were simulated by DFT calculations, applying the quantum mechanical/self consistent reaction field (virtual solvent) [QM/SCRF(VS)] approach. Only one mechanism correlates with the experimental kinetic data. The His-Cys catalytic diad is in an N/SH protonation state in the noncovalent papain-aldehyde Michaelis complex. His159 functions as a general base catalyst, abstracting a proton from the Cys25, whereas the activated thiolate synchronously attacks the inhibitor's carbonyl group. The final product of papain inhibition is the protonated neutral form of the hemithioacetal TC(OH), in agreement with experimental data. The predicted activation barrier g enz≠ = 5.2 kcal mol⁻¹ is close to the experimental value of 6.9 kcal mol⁻¹. An interpretation of the experimentally observed slow binding effect for peptidyl aldehyde inhibitors is presented. The calculated g cat≠ is much lower than the rate determining activation barrier of hemithioacetal formation in water, g w≠, in agreement with the concept that the preorganized electrostatic environment in the enzyme active site is the driving force of enzyme catalysis. We have rationalized the origin of the acidic and basic pK(a)'s on the k₂/K(S) versus pH bell-shaped profile of papain inhibition by peptidyl aldehydes.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21181719     DOI: 10.1002/prot.22939

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  8 in total

Review 1.  Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes.

Authors:  Reik Löser; Jens Pietzsch
Journal:  Front Chem       Date:  2015-06-23       Impact factor: 5.221

2.  Differentiating serine and cysteine protease mechanisms by new covalent QSAR descriptors.

Authors:  Michael Shokhen; Tamar Traube; Subramaniam Vijayakumar; Michal Hirsch; Neta Uritsky; Amnon Albeck
Journal:  Chembiochem       Date:  2011-03-24       Impact factor: 3.164

3.  Activation and selectivity of OTUB-1 and OTUB-2 deubiquitinylases.

Authors:  Dakshinamurthy Sivakumar; Vikash Kumar; Michael Naumann; Matthias Stein
Journal:  J Biol Chem       Date:  2020-04-07       Impact factor: 5.157

4.  Peptidyl cyclopropenones: reversible inhibitors, irreversible inhibitors, or substrates of cysteine proteases?

Authors:  Meital Cohen; Uriel Bretler; Amnon Albeck
Journal:  Protein Sci       Date:  2013-04-29       Impact factor: 6.725

5.  Crystal structure of the lytic CHAP(K) domain of the endolysin LysK from Staphylococcus aureus bacteriophage K.

Authors:  Marta Sanz-Gaitero; Ruth Keary; Carmela Garcia-Doval; Aidan Coffey; Mark J van Raaij
Journal:  Virol J       Date:  2014-07-26       Impact factor: 4.099

6.  Distinct Roles of Catalytic Cysteine and Histidine in the Protease and Ligase Mechanisms of Human Legumain As Revealed by DFT-Based QM/MM Simulations.

Authors:  Brigitta Elsässer; Florian B Zauner; Johann Messner; Wai Tuck Soh; Elfriede Dall; Hans Brandstetter
Journal:  ACS Catal       Date:  2017-07-14       Impact factor: 13.084

7.  An insight into the interaction between α-ketoamide- based inhibitor and coronavirus main protease: A detailed in silico study.

Authors:  Snehasis Banerjee
Journal:  Biophys Chem       Date:  2020-11-28       Impact factor: 2.352

8.  Azanitrile Inhibitors of the SmCB1 Protease Target Are Lethal to Schistosoma mansoni: Structural and Mechanistic Insights into Chemotype Reactivity.

Authors:  Adéla Jílková; Martin Horn; Jindřich Fanfrlík; Jim Küppers; Petr Pachl; Pavlína Řezáčová; Martin Lepšík; Pavla Fajtová; Petra Rubešová; Marta Chanová; Conor R Caffrey; Michael Gütschow; Michael Mareš
Journal:  ACS Infect Dis       Date:  2020-12-10       Impact factor: 5.084

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.